Inventaire - 友達とコミュニティはあなたのベストな図書館です

ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations

著者

Simon Durand

Leo Colmet Daage

この作品が含まれる作品: Oncotarget

出版日: 2019-08-13

main subject: 神経芽細胞腫

Cites articles 48

Date

タイトル

著者

2018-07-02

Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells

Angel M. Carcaboso, Mara Vinci, Diana Carvalho, Wendy J. Ingram, Andrew S Moore, Henry Mandeville, Ofelia Cruz, Michelle Monje, Chris Jones
2018-04-12

Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer

Satoshi Yoda, Jessica J Lin, Luc Friboulet, Harper Hubbeling, Adam Langenbucher, Mari Mino-Kenudson
2018-01-27

The ALK receptor in sympathetic neuron development and neuroblastoma.

Isabelle Janoueix-Lerosey, Lucille Lopez-Delisle, Olivier Delattre, Hermann Rohrer
2018-01-11

Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis

Isabelle Janoueix-Lerosey, Lucille Lopez-Delisle, Didier Surdez, Sylvain Baulande, Valentina Boeva, Olivier Delattre, Michel Peuchmaur, Caroline Louis-Brennetot, Cécile Pierre-Eugène, Virginie Raynal, Sandrine Grossetête-Lalami, Valérie Combaret
2017-05-01

Multiple Acquired Resistance Mutations of the ALK Tyrosine Kinase Domain after Sequential Use of ALK Inhibitors.
2017-05-31

Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on-target ALK inhibitors in neuroblastoma

Simon P Robinson, Yann Jamin, Udai Banerji, Louis Chesler
2016-12-20

Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome

Pichai Raman, Karthik Kalletla, Eric M. Sanford, Meaghan P Granger, Brian Weiss, Shakeel Modak, Irina Ostrovnaya
2016-11-24

Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse

Susan L. Cohn, Deborah A Tweddle
2016-11-10

Neuroblastoma

William A Weiss
2016-10-01

Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling

Diogo Ribeiro, Marie Arsenian-Henriksson
2016-07-07

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN

Jikui Guan, Yann Jamin, Simon P Robinson, Tommy Martinsson, Louis Chesler, Bengt Hallberg
2016-07-18

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer

Melissa Parks, Luc Friboulet, Ignaty Leshchiner, Satoshi Yoda, Gad Getz, Lecia V Sequist, Mari Mino-Kenudson
2016-01

The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma

Mark A. Lemmon
2015-06-29

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Isabelle Janoueix-Lerosey, Peter van Sluis, Valérie Combaret, Trevor J Pugh, Jan Koster, Rogier Versteeg, Thomas F Eleveld, Leo Colmet Daage, Olivier Delattre, Malcolm A Smith, Ellen van der Schoot, Huib N. Caron, Julie Gastier-Foster, Johannes H Schulte, Gudrun Schleiermacher, Eve Lapouble, Jean Michon, John M Maris, Patricia Legoix-né, Arlene Naranjo, Michael D Hogarty, Derek A Oldridge, Mathieu Chicard, Shahab Asgharzadeh, Ellen M Westerhout, Edward F. Attiyeh, Lori S Hart, Sharon J Diskin, Danny A Zwijnenburg, Godelieve A. M. Tytgat
2015-06-09

Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis

Anne-Sophie Defachelles, Isabelle Janoueix-Lerosey, Olivier Delattre, Gudrun Schleiermacher, Gaelle Pierron, Eve Lapouble, Jean Michon, Estelle Thebaud, Thomas Rio Frio, Valérie Combaret, Quentin Leroy, Nathalie Clement, Pascal Chastagner, Dominique Valteau-Couanet
2015-03-24

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment

Katleen De Preter, Nadine Van Roy, Isabelle Janoueix-Lerosey, Geneviève Laureys, Jan Cools, Olivier Delattre, Frank Speleman, Johannes H Schulte, Alex Cazes, Candy Kumps, Sara De Brouwer, Tom Van Maerken, Piotr Zabrocki
2015-02-04

Detection of tumor ALK status in neuroblastoma patients using peripheral blood

Valérie Combaret, Aurélien Marabelle
2014-11-10

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma

Daniel Weiser, Mark A. Lemmon
2014-01-01

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I Love, Wolfgang Huber, Simon Anders
2014-09-25

HTSeq--a Python framework to work with high-throughput sequencing data

Simon Anders, Paul Theodor Pyl, Wolfgang Huber
2014-07-30

Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity

Kornelia Polyak, Franziska Michor
2014-07-28

Emergence of new ALK mutations at relapse of neuroblastoma

Isabelle Janoueix-Lerosey, Valérie Combaret, Bram de Wilde, Jonas Abrahamsson, Ingrid Øra, Per Kogner, Tommy Martinsson, Olivier Delattre, Frank Speleman, Gudrun Schleiermacher, Gaelle Pierron, Eve Lapouble, Michel Peuchmaur, Jean Michon, Julie Cappo, Thomas Rio Frio, Quentin Leroy
2014-05-01

Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma

Katleen De Preter, Isabelle Janoueix-Lerosey, Lucille Lopez-Delisle, Claire Provost, Olivier Delattre, Frank Speleman, Gudrun Schleiermacher, Michel Peuchmaur, Caroline Louis-Brennetot, Cécile Pierre-Eugène, Alex Cazes, Romain Daveau, Candy Kumps, Aurélie Prignon, Hermann Rohrer
2014-06

The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer

Luc Friboulet, Ryohei Katayama, Adam S Crystal
2013-10-01

From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline

Stacey Gabriel, David Altshuler, Eric Banks, Mark DePristo, Ami Levy Moonshine, Khalid Shakir, Chris Hartl, Ryan Poplin
2013-10-01

Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

Ruth H Palmer, Bengt Hallberg
2013-04-16

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

Megan S Lim, Frank Balis, Keith D Wilner
2013-01-20

The genetic landscape of high-risk neuroblastoma

Carrie Sougnez, Kristian Cibulskis, Gad Getz, Daniel Auclair, Chandra Sekhar Pedamallu, エリック・ランダー, Olena Morozova, Trevor J Pugh, Inanc Birol, Matthew Meyerson, Stacey Gabriel, Andrey Sivachenko, Aaron McKenna, Chip Stewart, Readman Chiu
2012-07-01

The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma

Yann Jamin, Evon Poon, Florence Raynaud, Simon P Robinson, Louis Chesler, Nathanael Gray, 三田貴臣
2012-07-01

Targeted expression of mutated ALK induces neuroblastoma in transgenic mice

Alexander Schramm, Katleen De Preter, Filip Pattyn, Björn Menten, Jo Vandesompele, Lukas C Heukamp, Bram de Wilde, Martin Peifer, Lydia Meder, Sampurna Chatterjee, Frank Speleman
2012-03-04

Fast gapped-read alignment with Bowtie 2

Steven Salzberg, Ben Langmead
2012-02-22

Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes

Peter van Sluis, Rogier Versteeg, Ingrid Øra, Jan Koster, Huib N. Caron, Johan van Nes, Max M van Noesel, Arjan Lakeman

記事 - wd:Q92890423

Welcome to Inventaire

友達やコミュニティの図書館

もっと調べる